Immune evasion in the parasitic African trypanosome relies upon the silencing of variant surface glycoprotein genes that are found adjacent to telomeres. Work on the RAP1 telomere-binding protein now indicates that silencing spreads over a sufficient distance to repress these genes.
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Promoters drive gene expression by recruiting RNA polymerase but, in the vicinity of telomeres, promoters and their associated genes are silenced. This 'telomere position effect' phenomenon was first described in yeast [1] and was subsequently demonstrated in human cells and also in trypanosomes [2] . There are distinct types of telomeric silencing that are mediated by different factors and, depending upon the cell type, differ in the distance that the effect spreads from the telomere. A recent study on the trypanosome telomere-binding protein repressor/activator protein 1 (RAP1) now reveals that a far-reaching type of silencing extends over a sufficient distance to silence all but one of the promoters associated with variant surface glycoprotein (VSG) genes [3] .
The African trypanosome, Trypanosoma brucei, is a protozoan parasite of major medical and economic importance. These highly motile cells circulate in the mammalian host bloodstream and are spread among mammals by tsetse flies. Mammalian host immune mechanisms will likely eliminate any infectious agent that exposes a common set of epitopes for several days and this is why many pathogens have evolved strategies for phenotypic, clonal variation of surface proteins. African trypanosomes provide a sophisticated example of an immune evasion strategy that allows the establishment of a persistent infection in immunocompetent hosts. In trypanosomes, the VSG coats the cell and has the capacity to shield other surface molecules from immune attack [4] . There are many potential telomeric VSG expression sites (ESs; Figure 1 ) but only a single VSG is expressed by each cell and a co-ordinated switch can transfer active transcription from one telomere to another [5] . Importantly, silencing at all other ESs is critical to maintain monoallelic expression and the integrity of the evasion strategy.
The discovery of telomeric silencing offered a potential mechanism for the control of VSG genes in trypanosomes, as well as for the control of other subtelomeric gene families that are subject to monoallelic expression, such as those encoding olfactory receptors in mammals [6] and variant surface proteins (var genes) in the malaria parasite [7] . Crucially, the silencing effect would have to extend a long way from the telomere in these organisms if these genes were to be affected. Most of what we know about telomeric silencing mechanisms comes from studies in yeast where the repressive activity of RAP1 is exhibited at telomeres [8] , via binding to the characteristic short telomeric DNA repeats and recruitment of a silent information regulator (SIR) complex. This SIR complex spreads beyond the telomeric repeats and modifies histones, thus forming silent chromatin or heterochromatin at subtelomeres [9] . The SIR2 component of this complex is a histone deacetylase [10] , and disruption of SIR2-related proteins results in loss of telomeric gene silencing in yeast [11] and loss of telomeric var gene silencing in the malaria parasite [7] . These results also indicated that the silencing effect can spread great distances from the telomere. In the trypanosome, however, disruption of tbSIR2 resulted in only partial loss of silencing close to the telomere and VSG ES promoters were unaffected [12] ( Figure 1A ).
So how are telomeric VSG genes silenced? Telomere position effects that are mechanistically related to those described in yeast have obvious appeal and sequencing of the trypanosome genome presented new opportunities for research in this area. Yang and colleagues [3] now provide direct evidence that telomeres are involved in the regulation of VSG control by showing that depletion of trypanosome RAP1 increases VSG expression from all ESs by up to 50-fold ( Figure 1B,C) . tbRAP1 was initially identified via an interaction with a telomere repeat-binding factor (tbTRF1) and was then shown to colocalise with this protein and to associate with telomeric DNA, possibly directly via Myb-like DNA-binding domains. Depletion of tbRAP1 using an inducible RNA interference approach indicated that the protein is essential for growth but provided a window of opportunity to explore VSG expression. To provide good coverage, the authors exploited a recently published complement of ES sequences [13] and used quantitative real-time PCR to examine the expression of all fourteen VSGs located in telomeric ESs in the strain analysed. Importantly, VSG-specific antisera detected multiple VSGs on the surface of individual cells following tbRAP1 depletion, indicating that monoallelic VSG expression was severely compromised. Other recent studies support the idea that multiple chromatin modifiers cooperate to silence VSG ESs; deletion of a histone methyltransferase gene (tbDOT1B, named after yeast disruptor of telomeric silencing 1, DOT1) led to a slight increase in VSG transcription [14] , while depletion of a chromatin remodeler (tbISWI) led to increased VSG ES promoter activity, but did not increase VSG transcription [15] .
Telomeric silencing appears to be independent of the promoter or polymerase type and VSG ES promoters actually recruit RNA polymerase I, a polymerase restricted to nucleolar ribosomal RNA transcription in other eukaryotes; the single active VSG ES localises to an extra-nucleolar focus enriched in RNA polymerase I [16] . Yang and colleagues [3] also explored RNA polymerase I distribution in tbRAP1-depleted cells and found additional RNA polymerase I foci. Taken together, their results suggest that a tbRAP1-dependent mechanism blocks RNA polymerase I elongation at silent ESs, while another (as yet unknown) mechanism boosts transcription at the active ES ( Figure 1C) . The consequence is a 10,000-fold difference in expression from silent and active ESs.
The work of Yang and colleagues [3] reveals a related theme in telomeric silencing in yeast and trypanosomes. Over the past decade, histone modification has also emerged as a common mechanism of gene expression control. Of particular relevance here, a second histone deacetylase has been linked to silencing of subtelomeric genes in multiple independent studies [11, 17] and in each case the deacetylase silenced genes encoding surfaceexposed proteins. As with most exciting new findings, new questions follow. It will be particularly interesting to determine which trans-acting factors and, possibly, subtelomeric sequences control the spreading mechanism in trypanosomes ( Figure 1) ; tbRAP1 may spread silencing by recruiting histone modifiers or histone variants to VSG ESs, for example. In addition, VSG ESs contain a DNA-base modification known as 'J' that is restricted to a stage of the life cycle that expresses VSG in a monoallelic manner [18] . Since VSG ES silencing appears to be reinforced in this life-cycle stage [2, 19] , it will be interesting to determine whether J is responsible. It was recognized more than 25 years ago that the active VSG was adjacent to a telomere [20] and, as its name suggests, RAP1 activates as well as silences genes in yeast [8] . Could tbRAP1 also play a role in VSG activation?
Finally, it is important to remember that African trypanosomiasis is a neglected tropical disease (http:// www.who.int/). Since VSG silencing is so important for immune evasion and persistent infection, a better understanding of the silencing mechanism may reveal attractive targets for intervention strategies. There are many possible drug targets, but a target involved in VSG silencing and possibly other essential cellular functions could be particularly attractive. 
